Literature DB >> 384250

Drug therapy: Bromocriptine.

D Parkes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 384250     DOI: 10.1056/NEJM197910183011606

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

Review 1.  Paroxysmal sympathetic hyperactivity after severe brain injury.

Authors:  Devon Lump; Megan Moyer
Journal:  Curr Neurol Neurosci Rep       Date:  2014-11       Impact factor: 5.081

2.  Vitamin D metabolites and analogues, diphosphonates, danazol, and bromocriptine.

Authors:  C R Paterson; J Feely
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-21

3.  Psychotic reactions during treatment of pituitary tumours with dopamine agonists.

Authors:  T H Turner; J C Cookson; J A Wass; P L Drury; P A Price; G M Besser
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-27

4.  Bromocriptine-induced psychosis in acromegaly.

Authors:  C M Le Feuvre; A J Isaacs; O S Frank
Journal:  Br Med J (Clin Res Ed)       Date:  1982-11-06

5.  Use of the dopamine agonists bromocriptine and cabergoline in the management of risperidone-induced hyperprolactinemia in patients with psychotic disorders.

Authors:  S R Tollin
Journal:  J Endocrinol Invest       Date:  2000-12       Impact factor: 4.256

6.  Metergoline versus bromocriptine in the prevention of puerperal lactation. A double-blind clinical trial.

Authors:  F Scapin; S Buonaccorsi; G Tronconi; G Pellicciotta; A E Pontiroli
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 7.  Pituitary microadenomas: diagnostic and therapeutic trends.

Authors:  E M Grimes
Journal:  J Natl Med Assoc       Date:  1984-10       Impact factor: 1.798

8.  Growth of a microprolactinoma to a macroprolactinoma during estrogen therapy.

Authors:  M M Garcia; L P Kapcala
Journal:  J Endocrinol Invest       Date:  1995-06       Impact factor: 4.256

9.  Bromocriptine and psychosis: a literature review.

Authors:  A Boyd
Journal:  Psychiatr Q       Date:  1995

10.  Recovery of serum TSH and thyroid hormones after 3'isopropyl-3,5-diiodo-L-thyronine (DIIP) treatment: absence of inhibiting effect of bromocriptine on TSH secretion and evidence for autoregulation of serum T3 levels.

Authors:  N A Salomon-Montavon; A G Burger
Journal:  J Endocrinol Invest       Date:  1984-10       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.